Subtypes of Parkinson's disease: state of the field and future directions

被引:43
|
作者
Marras, Connie [1 ,2 ]
机构
[1] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Ctr, Toronto, ON M5T 2S8, Canada
[2] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON M5T 2S8, Canada
关键词
MILD COGNITIVE IMPAIRMENT; SLEEP BEHAVIOR DISORDER; DATA-DRIVEN APPROACH; CLINICAL SUBTYPES; NONMOTOR SYMPTOMS; MOTOR SUBTYPES; HETEROGENEITY; DOMINANT; COHORT; TREMOR;
D O I
10.1097/WCO.0000000000000219
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Previously, outstanding questions have been identified including the relationship of proposed subtypes to etiology, underlying biology, and prognosis. This situation presents an opportunity for major developments in the field. The review summarizes the progress made over the past 1-2 years. Recent findings The etiologic, physiological, and clinical differences between tremor dominant, postural instability gait disorder, and indeterminate phenotypes have been further explored, finding genetic influences, functional imaging and clinical differences. New cluster analyses suggest that nonmotor features are important aspects of Parkinson's disease subtypes, but there was little association found between tremor-dominant /postural instability gait disorder phenotype and nonmotor symptoms. In the cognitive realm, empirically derived subtypes of PD-MCI did not map well onto cognitive subtypes derived using a data-driven approach. In data-driven subtype research, important survival differences between subtypes were identified within the PROPARK database. It will be important to revisit PD-MCI classification to consider subtyping based upon data that relate cognitive phenotype to prognosis. Given the traction that traditional motor subtyping has had in the field it would be of value to consider how nonmotor symptom clusters can be used with or alongside the motor subtypes. Finally, incorporating subtypes into clinical trials remains a significant gap in Parkinson's disease research.
引用
收藏
页码:382 / 386
页数:5
相关论文
共 50 条
  • [21] Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions
    Lauretani, Fulvio
    Longobucco, Yari
    Ravazzoni, Giulia
    Gallini, Elena
    Salvi, Marco
    Maggio, Marcello
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (05) : 1 - 11
  • [22] Lixisenatide in early parkinson's disease: efficacy, safety, and future directions: a correspondence
    Irfan, Hamza
    Ul Muneer, Siraj
    Maheshwari, Ashoney Bai
    Kumar, Nikil
    Iftikhar, Sana
    [J]. NEUROSURGICAL REVIEW, 2024, 47 (01)
  • [23] Drugs Used to Treat Parkinson's Disease, Present Status and Future Directions
    Abdel-Salam, Omar M. E.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2008, 7 (04) : 321 - 342
  • [24] Parkinson's disease: general features, effects of levodopa treatment and future directions
    Freire, Marco Aurelio M.
    Santos, Jose Ronaldo
    [J]. FRONTIERS IN NEUROANATOMY, 2010, 4
  • [25] Treatment of Parkinson's Disease with Cognitive Impairment: Current Approaches and Future Directions
    Sun, Chichun
    Armstrong, Melissa J.
    [J]. BEHAVIORAL SCIENCES, 2021, 11 (04)
  • [26] Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease
    Kathleen A. Maguire-Zeiss
    Howard J. Federoff
    [J]. Journal of Neural Transmission, 2010, 117 : 1019 - 1025
  • [27] Current status and future directions of gene expression profiling in Parkinson's disease
    Greene, James G.
    [J]. NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 76 - 82
  • [28] Advance care planning in Parkinson's disease: ethical challenges and future directions
    Sokol, Leonard L.
    Young, Michael J.
    Paparian, Jack
    Kluger, Benzi M.
    Lum, Hillary D.
    Besbris, Jessica
    Kramer, Neha M.
    Lang, Anthony E.
    Espay, Alberto J.
    Dubaz, Ornella M.
    Miyasaki, Janis M.
    Matlock, Daniel D.
    Simuni, Tanya
    Cerf, Moran
    [J]. NPJ PARKINSONS DISEASE, 2019, 5 (01)
  • [29] Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease
    Maguire-Zeiss, Kathleen A.
    Federoff, Howard J.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (08) : 1019 - 1025
  • [30] Treatment of motor fluctuations in Parkinson's disease: recent developments and future directions
    Ramirez-Zamora, Adolfo
    Molho, Eric
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (01) : 93 - 103